GO
Loading...

Broken Stock or Broken Company?

Thursday, 28 Jun 2012 | 6:15 PM ET

Last week, Celgene announced it was pulling its Revlimid application in Europe, and Mad Money host Jim Cramer explains why he thinks investors should buy into the stock now.